Cargando…
Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway
BACKGROUND: Hepatocellular carcinoma (HCC) is an aggressive malignant disease with poor prognosis. Recent advances suggest the existence of cancer stem cells (CSCs) within liver cancer, which are considered to be responsible for tumor relapse, metastasis, and chemoresistance. However, novel therapeu...
Autores principales: | Li, Binghua, Cao, Yajuan, Meng, Gang, Qian, Liyuan, Xu, Tiancheng, Yan, Chen, Luo, Ouyang, Wang, Shaohe, Wei, Jiwu, Ding, Yitao, Yu, Decai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355660/ https://www.ncbi.nlm.nih.gov/pubmed/30555042 http://dx.doi.org/10.1016/j.ebiom.2018.11.063 |
Ejemplares similares
-
Liver-enriched Genes are Associated with the Prognosis of Patients with Hepatocellular Carcinoma
por: Li, Binghua, et al.
Publicado: (2018) -
Kidney-type glutaminase (GLS1) is a biomarker for pathologic diagnosis and prognosis of hepatocellular carcinoma
por: Yu, Decai, et al.
Publicado: (2015) -
Development and Validation of a Three-gene Prognostic Signature for Patients with Hepatocellular Carcinoma
por: Li, Binghua, et al.
Publicado: (2017) -
Kidney-type glutaminase is a biomarker for the diagnosis and prognosis of hepatocellular carcinoma: a prospective study
por: Zhang, Laizhu, et al.
Publicado: (2023) -
Paired assessment of liver telomere lengths in hepatocellular cancer is a reliable predictor of disease persistence
por: Feng, Wendu, et al.
Publicado: (2017)